mjam - that's my question The original business model involved partnering with major pharmas and/or medical groups to match patients and drugs based genetic predisposition. A drug company by definition, would make new drugs. Perhpas we are talking about altering established drugs to bypass genetic problems, I don't know. I also don't know how that would bypass the FDA. So frankly, I am not sure what Dr. Frudakis meant. I am not implying that he had nothing in mind. I would just like to undestand it.
News 
Market Data 
Discover 
AI
